Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: comparison of factor product use, bleed rates and pharmacokinetics - Nummi, V; Lehtinen, A-E; Iorio, A; Szanto, T; Lassila, R (Haemophilia, 2022)